Pharmacy Report Archives - Page 5 of 152 - Becker's Hospital Review

Drug tariff begins tomorrow | Who wins under CMS' 340B proposal? | Memorial Hermann's 'aggressive' bet on retail pharmacy | 10 systems hiring pharmacy leaders | A new reporting push for compounded drugs

Plus: FDA panel reject Duchenne therapy over efficacy concerns July 30, 2026 1. Trump’s drug tariff takes effect tomorrow: What to know Full story 2. 5 pharmacies and counting: Why Memorial Hermann chose ‘aggressive’ retail expansion Full story 3. Traditional training moves…

Medicare Part D shakeup ahead | 4 pharmacy policy changes to watch | CVS looks to dismiss 340B lawsuits | FDA releases 17 peptide drug guidances | Pa. pharmacies face estradiol patch shortage

Plus: 24 health systems adding new C-suite roles July 29, 2026 1. CMS to end Medicare Part D stabilization program Full story 2. 4 pharmacy policy changes to watch Full story 3. Pharmacy is transforming from a cost center to a…

Betting sites take on FDA drug approvals | Judge rejects ND's bid to keep 340B law | Nationwide thyroid drug recall | FDA OKs new ADHD drug | Medicare pharmacy access falls short

Plus: ECRI, ISMP warn against FDA panel’s peptide compounding vote July 28, 2026 1. Betting sites take on FDA drug approvals, trial results Full story 2. Judge rejects North Dakota bid to pause 340B ruling Full story 3. How are…

Pharmacy tech pay by state | FDA panel OKs 6 peptides, rejects 1 | 6 GLP-1 study findings | Sanofi reports insulin pen supply disruption | Pharmacy prices to rise 3.5% in '27

Plus: Pharmacy advocacy groups urge 340B oversight shift to CMS July 27, 2026 1. Pharmacy technician median pay by state Full story 2. 6 GLP-1 findings to know Full story 3. Drug pricing pressure, 340B uncertainty, PBM dynamics and ultra-high-cost…

FDA weighs peptide compounding | 6 new drug shortages | Where the GLP-1 compounding fight stands | Ark. sues drugmakers over 340B | 10 systems seeking pharmacy leaders

Plus: Allergy medication recalled over potential heartburn drug contamination July 23, 2026 1. FDA to vote on peptide compounding: What to know Full story 2. 6 new drugs in shortage Full story 3. 340B complexity is growing. Watch how experts…

Providence names pharmacy chief | Henry Ford sues CVS over 340B losses | Trump proposes generic drug tariffs | HHS wins 340B rebate ruling | ASHP adopts 16 new pharmacy policies

Plus: GLP-1s cut long-term sick leave 17%: 4 study notes July 22, 2026 1. Providence names chief pharmacy officer Full story 2. Henry Ford Health sues CVS, alleges 340B pricing scheme Full story 3. Is your pharmacy losing margin to…

Pharmacist pay by state | UNC dismisses 340B underpayment lawsuits | Novo sues Lilly over GLP-1 ads | Iowa sanctions hospital pharmacy | GLP-1 compounders find FDA loophole

Plus: New Trump tariffs spare patented drugs: 3 things to know July 21, 2026 1. Pharmacist median pay by state Full story 2. UNC Health dismisses 340B underpayment lawsuits targeting Humana Full story 3. Prescription to pill takes 21 days.…

TrumpRx at 6 months: Has it worked? | Hidden costs of the GLP-1 boom | The drug pricing that could save Medicaid $8.6B | 9 pharmacy groups warn vaccine access at risk | Md. skipped audits on $675M in pharmacy claims

Plus: Conn. pauses plan to pursue lower-cost GLP-1s July 20, 2026 1. TrumpRx at 6 months: Has the drug-pricing experiment delivered? Full story 2. The hidden cost of the GLP-1 boom: 5 notes Full story 3. Becker’s 3rd Annual Fall…

Drug costs now hospitals' fastest-growing threat | AHA backs HHS in 340B fight | Half of new drug shortages tied to one manufacturer | FDA OKs pill to slash cholesterol | 10 systems hiring pharmacy leaders

Plus: CVS aims to lead Trump admin’s interoperability push July 16, 2026 1. Drug costs are becoming hospitals’ fastest-growing financial threat Full story 2. AHA backs HHS in AbbVie 340B court fight: 4 notes Full story 3. US drug spend hit…

CVS, FTC reach $13B insulin deal | Where pharmacy automation is delivering ROI | Children's hospitals' drug shortage playbook | Employer GLP-1 coverage holds at 36% | Alaska expands pharmacists' scope

Plus: How CHOP increased naloxone co-prescribing from 3% to 84% July 15, 2026 1. How children’s hospitals manage the nation’s most stubborn drug shortages Full story 2. CVS Caremark, FTC settle insulin pricing case for $13B Full story 3. Most…